US Patent Issued to INSERM (INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE), UNIVERSITE DE PARIS on June 3 for "Antibodies having specificity for CD38 and uses thereof" (French Inventors)

ALEXANDRIA, Va., June 4 -- United States Patent no. 12,319,745, issued on June 3, was assigned to INSERM (INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE) (Paris) and UNIVERSITE DE PARIS (Paris).

"Antibodies having specificity for CD38 and uses thereof" was invented by Armand Bensussan (Paris), Jean-Christophe Bories (Paris), Maxime Fayon (Paris) and Carolina Martinez-Cingolani (Paris).

According to the abstract* released by the U.S. Patent & Trademark Office: "CD38 is also expressed in a variety of malignant hematological diseases, including multiple myeloma. In the present invention, the inventors have generated a new antibody against CD38 that could be suitable for producing bispecific antibodies as well as CAR-T cells. In pa...